Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: March 30, 2023

COLESTID Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

When do Colestid patents expire, and what generic alternatives are available?

Colestid is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Colestid

A generic version of COLESTID was approved as colestipol hydrochloride by IMPAX LABS on May 2nd, 2006.

  Sign Up

Drug patent expirations by year for COLESTID
Drug Prices for COLESTID

See drug prices for COLESTID

Recent Clinical Trials for COLESTID

Identify potential brand extensions & 505(b)(2) entrants

University of WashingtonPhase 3
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all COLESTID clinical trials

US Patents and Regulatory Information for COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer COLESTID colestipol hydrochloride GRANULE;ORAL 017563-003 Sep 22, 1995 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.